Valeant Pharmaceuticals faced no shortage of arguments in the long dark night of controversy that's wreaked havoc on its stock price. Now, a new dispute is brewing with Johnson & Johnson over responsibility in talc lawsuits.
Eyegate Pharmaceuticals Inc. stock surged 11% in premarket trade Monday after the company said it had received its first milestone payment from Valeant Pharmaceuticals International Inc. resulting from a February licensing deal for Eyegate's...
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.
You may also be interested in articles related to Valeant Pharmaceuticals International (VRX):